HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment.

AuthorsN S Karadsheh, Q Shaker, B Ratroat
JournalHaematologica (Haematologica) Vol. 86 Issue 6 Pg. 659-60 (Jun 2001) ISSN: 0390-6078 [Print] Italy
PMID11418378 (Publication Type: Case Reports, Letter)
Chemical References
  • Dopamine Antagonists
  • Cytochrome Reductases
  • Cytochrome-B(5) Reductase
  • Metoclopramide
  • Methylene Blue
Topics
  • Adult
  • Contraindications
  • Cytochrome Reductases (blood, deficiency)
  • Cytochrome-B(5) Reductase
  • Dopamine Antagonists (administration & dosage, adverse effects)
  • Glucosephosphate Dehydrogenase Deficiency (blood, complications)
  • Humans
  • Jordan
  • Male
  • Methemoglobinemia (chemically induced, drug therapy)
  • Methylene Blue (administration & dosage)
  • Metoclopramide (administration & dosage, adverse effects)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: